Navigation Links
Projecis Signs "Top 5" Worldwide Generic Drug Maker and Niche European CRO as Sales Climb for Software Company
Date:11/2/2012

SAN DIEGO, Nov. 2, 2012 /PRNewswire/ -- Projecis, Inc., a content and collaboration software company, has recently licensed its flagship platform to a "top 5" worldwide generic drug company and a niche contract research organization (CRO) operating in Central and Eastern Europe, August Research.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02918LOGO)

The generic drug maker intends to deploy Projecis over the next several months to its staff and use the platform as a centralized project information hub.  With the projects they are conducting and the growth they are planning in the U.S. and abroad, Projecis provides a much needed tool to coordinate information among the firm's teams.

August Research, headquartered in Bulgaria, is a CRO that performs Phase I-IV clinical trials throughout Central and Eastern Europe.  They are implementing Projecis for clinical projects as well as internal operations.

"Projecis provides a great project team information and collaboration platform," says Dana Niedzielska, CEO of August Research.  "With teams working across time zones and countries, special attention is needed to coordinate tasks, updates and information so that project efforts are focused and efficient, and we can achieve the best results possible."

Projecis is currently running pilots at a large pharmaceutical firm and other CROs, as companies embrace the advantages of deploying Projecis for their clinical research programs.

"It's becoming clear that our software is gaining traction in the biopharma industry, with both small and large firms adopting Projecis daily," says Russ Holmes, CEO of Projecis.  "Our belief is that our robust communications package, strong collaborative features and smart project management functions serve the industry, which is need of an 'all-in-one' platform for working with project teams and information in a centralized environment."

At less than 50 cents per day/per seat, Projecis is one of the most cost-effective project collaboration and management solutions on the market.  Projecis offers a free 10-day trial offer via its website.

About Projecis
Projecis is a knowledge convergence platform that enables project stakeholders to easily connect teams, organize data, and disseminate information for better business decision-making. Users can access project status, cost measures, files, data, member profiles (including LinkedIn©) – even video news updates – via this secure, web-based platform. Team exchange is enhanced with Communication 2.0 features for connecting members over online chat/VoIP, email, text, landline or mobile phone. www.Projecis.com.

Twitter: @Projecis
Facebook: Projecis
Why Projecis? - VIDEO

Media Contact:
Bonnie Shaw
Clearpoint Agency
Bonnie@clearpointagency.com
760.230.2424


'/>"/>
SOURCE Projecis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Henry Schein Signs Agreement To Expand Animal Health Presence To Ireland With The Acquisition Of C&M Vetlink
2. Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 2014
3. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
4. CHMP Recommends Approval of Cialis for the Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia
5. Eutropics Pharmaceuticals signs $1.5M NCI/SBIR contract to develop companion diagnostic for guiding Multiple Myeloma treatments
6. Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company
7. One Of Colorados Largest Physician Networks Signs Agreement To Join Colorado Health Information Exchange
8. Comprehensive Care Corporation Signs Agreement With WellDyneRx as Part of CompCares New Pharmacy Savings Center Program
9. PTS, Inc. Signs Agreement to Provide Point-of-Care Lipid Testing to Life Line Screening
10. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
11. HealthTrust Signs Agreement with Safecor Health for Medication Repackaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Jersey and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the ... Series D investment round on February 5, 2016. The ... Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and ... SCP Vitalife Partners, Generali Financial Holdings and both the ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... 2016 On Tuesday, February 9th, the ... with its Arthritis Advisory Committee to discuss ... & Johnson,s Remicade and most likely the ... U.S. The Biologics Prescribers Collaborative (BPC) along ... for Patient Access, American Association of Clinical ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... company is unveiling its revolutionary new 2.0 version at the International Roofing Expo ... “put the power of the world's most advanced weather technology in the hands ...
(Date:2/10/2016)... Garland, TX (PRWEB) , ... February 10, 2016 ... ... the commencement of a master charity program created to assist the local community. ... closely with community leaders and nonprofit organizations in the area. Their goal is ...
(Date:2/10/2016)... ... , ... Ongoing news of the ravages of traumatic brain injury (TBI) among ... that takes a closer look at cases of TBI being managed by their members. ... among the aging population, and identifies the challenges associated with their care. , During ...
(Date:2/10/2016)... ... 2016 , ... Armune BioScience signed a definitive agreement with ... centers across the country. Launched in April of 2015, Apifiny is the only cancer ... Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... been awarded the prestigious Distinguished Emerald Club of the World award, as determined ... magazine, one of the most respected trade publications serving private clubs. , “We’d ...
Breaking Medicine News(10 mins):